Cargando…
Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric Malignancies
Precision oncology trials for pediatric cancers require rapid and accurate detection of genetic alterations. Tumor variant identification should interrogate the distinctive driver genes and more frequent copy number variants and gene fusions that are characteristics of pediatric tumors. Here, we eva...
Autores principales: | Lorentzian, Amanda, Biegel, Jaclyn A, Ostrow, D Gigi, Rolf, Nina, Liu, Chi-Chao, Rassekh, S Rod, Deyell, Rebecca J, Triche, Timothy, Schultz, Kirk R, Rozmus, Jacob, Reid, Gregor S D, Lim, C James, Lange, Philipp F, Maxwell, Christopher A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447067/ https://www.ncbi.nlm.nih.gov/pubmed/30976750 http://dx.doi.org/10.1093/jncics/pky079 |
Ejemplares similares
-
PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways
por: Uzozie, Anuli C., et al.
Publicado: (2021) -
Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia
por: Lorentzian, Amanda C., et al.
Publicado: (2023) -
Adaptation of the Th-MYCN Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease
por: Rahavi, Seyed M., et al.
Publicado: (2023) -
Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations
por: Shen, Lishuang, et al.
Publicado: (2021) -
Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications
por: Shen, Lishuang, et al.
Publicado: (2021)